Ravelcare
RAVELCARELTD NSE
Ravelcare
FMCGNSE: RAVELCARELTD BSE: RAVEL FMCG Products
Key Fundamentals
SMEFMCG ProductsFMCGMarket Cap
₹72.20 Cr
Volatility
Moderate
P/E Ratio
14
EBITDA
₹7.06 Cr
Return on Equity
50.73%
Debt to Equity
0
Book Value
₹54.54
52W High
₹215
52W Low
₹100
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company is almost debt free.
- Company has delivered good profit growth of 119% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.8%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 45.1 to 96.3 days.
- Working capital days have increased from 45.6 days to 119 days
Growth Rate
Revenue Growth
6.52% lower than
3Y
Net Income Growth
-0.77% lower than
3Y
Cash Flow Change
-108% higher than
3Y
ROE
-47.65% lower than
3Y
ROCE
-47.72% higher than
3Y
EBITDA Margin (Avg.)
-7.41% higher than
3Y
Quarterly Results
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 14.58 | 12.56 |
| Expenses | 13.3 | 9.84 |
| Operating Profit | 1.28 | 2.72 |
| OPM % | 8.78% | 21.66% |
| Other Income | 0.27 | 0.04 |
| Interest | 0 | 0 |
| Depreciation | 0.05 | 0.03 |
| PBT | 1.5 | 2.73 |
| Tax % | 0.67% | 28.57% |
| Net Profit | 1.5 | 1.95 |
| EPS in Rs | 3 | 2.84 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | — | 0.79 | 3.48 | 22.06 | 24.98 | 26.95 |
| Expenses | — | 1 | 2.97 | 15.35 | 18.16 | 19.88 |
| Operating Profit | — | -0.21 | 0.51 | 6.71 | 6.82 | 7.07 |
| OPM % | — | -26.58% | 14.66% | 30.42% | 27.3% | 26.23% |
| Other Income | — | 0 | 0 | 0.19 | 0.32 | 0.09 |
| Interest | 0 | 0.01 | 0 | 0.07 | 0.01 | 0.02 |
| Depreciation | 0 | 0 | 0 | 0.02 | 0.1 | 0.07 |
| PBT | -0.11 | -0.22 | 0.51 | 6.81 | 7.03 | 7.07 |
| Tax % | 0% | 0% | -11.76% | 25.11% | 27.74% | 27.02% |
| Net Profit | -0.11 | -0.23 | 0.56 | 5.1 | 5.09 | 5.15 |
| EPS in Rs | -220 | -460 | 1,120 | 10,200 | 10.17 | 7.51 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 0.01 | 5.01 | 6.86 |
| Reserves | -0.12 | -0.35 | 0.16 | 5.25 | 5.34 | 30.55 |
| Borrowings | 0.12 | 0.42 | 0.41 | 0.04 | 0 | 0 |
| Other Liabilities | 0 | -0.01 | 1.17 | 4.18 | 1.28 | 2.92 |
| Total Liabilities | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
| Fixed Assets | 0 | 0 | 0.01 | 0.22 | 0.16 | 0.11 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2.48 |
| Investments | 0 | 0 | 0 | 0.79 | 3.07 | 4.51 |
| Other Assets | 0.01 | 0.07 | 1.74 | 8.47 | 8.4 | 33.23 |
| Total Assets | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | — | -0.41 | 1 | 6.49 | -3.18 | -17.47 |
| Investing | — | 0 | -0.01 | -6.92 | 3.81 | -4.12 |
| Financing | — | 0.41 | -0.01 | -0.44 | -0.04 | 21.91 |
| Net Cash Flow | — | 0 | 0.98 | -0.87 | 0.59 | 0.32 |
| Free Cash Flow | — | -0.41 | 0.99 | 6.26 | -3.22 | -19.97 |
| CFO/OP | — | 195 | 196 | 122 | -22 | -231 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 0 | 0 | 2.81 | 36.24 | 96.29 |
| Inventory Days | — | 0 | 307 | 24.18 | 104 | 90.21 |
| Days Payable | — | — | 149 | 72.55 | 21.22 | 71.81 |
| Cash Conversion Cycle | — | 0 | 158 | -45.55 | 119 | 115 |
| Working Capital Days | — | -166 | -87.05 | -31.93 | 49.83 | 119 |
| ROCE % | — | -466.67% | 154.55% | 234.01% | 89.33% | 30.49% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ravelcare insights
41 extracted metrics + investor summaries across FY21–FY26.
Documents
2
Closure of Trading Window
21 Mar - Ravelcare Ltd: Trading window closed Apr 1, 2026 until 48 hours after audited results for half/year ended Mar 31, 2026. 21 Mar - Ravelcare Ltd: Trading window closed Apr 1, 2026 until 48 hours after audited results for half/year ended Mar 31, 2026.
3
Board Meeting Outcome for Outcome Of Board Meeting
17 Mar - Appointed Alpesh Rajesh Bhatt as Company Secretary & Compliance Officer effective March 17, 2026. 17 Mar - Appointed Alpesh Rajesh Bhatt as Company Secretary & Compliance Officer effective March 17, 2026.
4
Appointment of Company Secretary and Compliance Officer
17 Mar - Appointed Alpesh Rajesh Bhatt as Company Secretary & Compliance Officer effective March 17, 2026. 17 Mar - Appointed Alpesh Rajesh Bhatt as Company Secretary & Compliance Officer effective March 17, 2026.
5
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
6 Mar - Company Secretary Ms. Esha Srivastava resigned, effective March 6, 2026; relieved same day. 6 Mar - Company Secretary Ms. Esha Srivastava resigned, effective March 6, 2026; relieved same day.
Frequently Asked Questions about Ravelcare
What does Ravelcare Ltd do?
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of products.[1]
Where is Ravelcare Ltd (544629) listed?
Ravelcare Ltd trades as RAVELCARELTD on the NSE and under code RAVEL on the BSE.
Which sector does Ravelcare Ltd belong to?
Ravelcare Ltd is classified under the FMCG sector, in the FMCG Products industry.
What is the market capitalisation of Ravelcare Ltd?
Ravelcare Ltd has a market capitalisation of ₹72.2 Cr, which places it in the Small Cap band.
What is the PE ratio of Ravelcare Ltd?
Ravelcare Ltd trades at a PE ratio of 14.00, against a book value of ₹54.54 per share.
What is the 52-week high and low of Ravelcare Ltd?
Over the last 52 weeks Ravelcare Ltd has traded between ₹100 and ₹215.
What is the Return on Equity (ROE) of Ravelcare Ltd?
Ravelcare Ltd reported a return on equity of 50.73%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544629.md for Ravelcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.